Search
Wednesday 22 April 2015
  • :
  • :

Stocks in a bear Hug: Magnum Hunter Resources (NYSE:MHR), CNH Industrial NV (NYSE:CNHI), Hershey (NYSE:HSY), Achillion Pharmaceuticals, (NASDAQ:ACHN)

On Monday, Magnum Hunter Resources Corp (NYSE:MHR)’s shares declined -2.23% to $2.63.

Magnum Hunter Resources Corp (MHR) declared that it has declared a monthly cash dividend on the Company’s 10.25% Series C Cumulative Perpetual Preferred Stock (“Series C Preferred Stock”), a monthly cash dividend on the Company’s 8.0% Series D Cumulative Preferred Stock (“Series D Preferred Stock”) and a monthly cash dividend on the Company’s 8.0% Series E Cumulative Convertible Preferred Stock (“Series E Preferred Stock”). The outstanding shares of Series E Preferred Stock are represented by depositary shares (the “Depositary Shares”), each representing a 1/1,000th interest of a share of Series E Preferred Stock.

The dividend on the Series C Preferred Stock, which is for the month of April 2015, is payable on April 30, 2015, to holders of record at the close of business on April 15, 2015. The payment will be an annualized 10.25% per share, which is equivalent to about $0.2135 per share, based on the $25.00 per share liquidation preference of the Series C Preferred Stock.

Magnum Hunter Resources Corporation, an independent oil and gas company, explores for, exploits, attains, develops, and produces crude oil, natural gas, and natural gas liquid resources in the United States.

CNH Industrial NV (NYSE:CNHI)’s shares gained 0.49% to $8.53.

CNH Industrial NV (CNHI) declared that its financial results for the first quarter of 2015 will be released on Thursday, April 30.

A live audio webcast of the Q1 conference call will start at 5:00 p.m. CET / 4:00 p.m. GMT / 11:00 a.m. EDT on Thursday, April 30.

CNH Industrial N.V. designs, produces, markets, sells, and finances agricultural and construction equipment, trucks, commercial vehicles, buses, and specialty vehicles, engines, transmissions, and axles worldwide.

At the end of Monday’s trade, Hershey Co (NYSE:HSY)‘s shares dipped -2.05% to $98.21.

, Hershey Co (HSY) declared that it has been recognized as one of Corporate Responsibility Magazine’s 100 Best Corporate Citizens. The company was ranked No. 45. This is the first time the company has been in the top 50 and underscores the company’s commitment to using its business expertise for good around the world.

The Hershey Company manufactures, imports, markets, distributes, and sells confectionery products. The company operates through two segments, North America; and International and Other.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), ended its Monday’s trading session with -2.05% loss, and closed at $10.05.

Achillion Pharmaceuticals, Inc. (ACHN) declared that it will present three posters, counting two late breaker abstracts, at the 50th Annual Meeting of the European Association for the Study of the Liver (EASL) during The International Liver Congress 2015.

Poster presentations will comprise Phase 1 results on ACH-3422, a NS5B nucleotide polymerase inhibitor, and detailed results from the Phase 2 proxy study evaluating ACH-3102, a second-generation NS5A inhibitor, and sofosbuvir following 6- and 8-week treatment durations for treatment-naive genotype 1 HCV. The congress is being held April 22 — 26 in Vienna, Austria. The abstracts can be accessed on the EASL website at https://ilc-congress.eu/ and posters will be accessible following their presentation under the resources section of the Achillion website at http://www.achillion.com.

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *